T36.AX6
Underdosing of fluoroquinolone antibiotics
Clinical Classification Guidelines
Medical Intelligence & Overview
Underdosing of fluoroquinolone antibiotics, classified under ICD-10 code T36.AX6, refers to the administration of a dosage that is lower than the prescribed amount of these medications. Fluoroquinolones are a class of antibiotics used to treat a variety of bacterial infections, including urinary tract infections, respiratory infections, and skin infections. Proper dosing is crucial to effectively eliminate the infection and prevent the development of antibiotic resistance. When underdosing occurs, it can lead to treatment failure, prolonged illness, and increased risk of resistance, which makes managing bacterial infections more challenging.
Causes & Symptoms
Clinical Causes: Patient misunderstanding of prescription instructions Intentional reduction of dose due to fear of side effects Medication shortage or supply issues Financial constraints limiting medication purchase Poor adherence to prescribed treatment regimen Physician prescribing errors or miscalculations Alteration of dosage without medical consultation
Key Symptoms: Persistent or worsening infection signs despite treatment Unresolved fever or malaise Symptoms recurring after initial improvement Development of resistant bacterial strains (though not always immediately evident)
Diagnostic & Treatment
Diagnosis Path: Diagnosis primarily involves reviewing the patient's medication history and assessing adherence to prescribed doses. Healthcare providers may perform laboratory tests, such as bacterial cultures and susceptibility testing, to evaluate treatment effectiveness. Additionally, clinical evaluation of symptoms and signs helps determine whether underdosing might be contributing to ongoing infection.
Treatment Protocols: Addressing underdosing involves ensuring appropriate medication adherence through patient education and counseling. Healthcare providers may modify the treatment plan by adjusting the dose or duration of therapy, based on clinical response and laboratory findings. Managing underlying causes of non-adherence, such as financial barriers or misunderstandings, is crucial. Monitoring for and preventing antibiotic resistance is also a key component of ongoing care.
Clinical Advice & FAQs
Billing Guidance
Is T36.AX6 a billable ICD-10 code?
Yes, T36.AX6 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T36.AX6?
Clinical documentation must specify the nature of Underdosing of fluoroquinolone antibiotics and any associated comorbidities for accurate reporting.
Cite this Clinical Reference